NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
05/06/2025
Voltar para busca
Dado oficial do USPTO
SKYLA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
57
Atualização mais recente
24/06/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 10
Data de depósito
08/11/2011
Data de registro
17/03/2015
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
05/06/2025
Última transação
24/06/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
30/04/2012
Primeiro uso no comércio
30/04/2012
Código do desenho
3
Tipo de titular
03
Localização do titular
HSINCHU CITY, TW
Examinador
BLAIR, JASON
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the wording "SKYLA" to the right of a miscellaneous oval design of three intersecting ovals lined where they overlap.
Titulares e representantes
Titulares
S. B. (pessoa física)
L. C. (pessoa física)
Representantes
Michael T. Smith Birch Stewart Kolasch & Birch, LLP
Classificação técnica
Classes Nice
Classe 5Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Amino acids for medical or veterinary diagnostic purposes; Bacterial and bacteriological preparations for medical or veterinary diagnostic purposes; Biochemical preparations for medical or veterinary purposespreparations for blood analysis and body fluid analysis; Biological and chemical preparations and reagents for medical or veterinary usereagents for biochemistry analysisimmunoassay and nucleic acid testing; Biological indicators for monitoring sterilization processes for medical or veterinary purposes; Chemical reagents for medical or veterinary diagnostic purposes; Diagnostic preparations for medical or veterinary purposes; Diagnostic reagents and contrast media for medical or veterinary diagnostic use; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Electrophoresis gels for medical or veterinary diagnostic purposes; Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents for the analysis of body fluids; Nucleic acid sequences and chemical reagents for medical or veterinary diagnostic purposes; Plant extracts for medical or veterinary diagnostic purposes; Reagents and media for medical and veterinary diagnostic purposes
Classe 10
Blood pressure and diabetic diagnostic medical devices; Breath gas analyzers for medical diagnostics; Cytometers for medical diagnostic use; Diagnostic apparatus for the detection of periodontal disease; Diagnostic apparatus for the detection of cancer; Diagnostic kits consisting primarily of probesbuffers and reagents for use in microbial testing; Dynamometers for diagnostic muscle strength testing; Electromagnetic medical diagnostic imaging apparatus; Flow cytometers and flow-based analyzers providing cell and particle analysisdetectioncounting for medicalclinicalmedical diagnostictherapeutic uses; Flow cytometers for medical diagnostic uses; Hematology analyzers for medical diagnostic uses; Instrument and apparatus systems for medical diagnostic uses consisting of flow cytometershematology analyzerssample preparation devicerelated data management software sold as a unit; Medical apparatus and instruments for diagnostic radiopharmaceutical use; Medical apparatus and instrument for diagnostic useapparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testingcytology and cell-based testing; Medical diagnostic apparatusanalytical apparatus for medical purposes and blood pressure measuring apparatus; Medical diagnostic apparatus for detecting cancer; Medical diagnostic instruments for the analysis of body fluids; Medical dose meter that measures the total radiation dose received by a patient during a diagnostic procedure; Medical instrument for cardiovascular diagnostics; MRI diagnostic apparatus; Nuclear medicine diagnostic imaging apparatus; Organoleptic diagnostic testing apparatus for medicaldental or cosmetic use; Orthopedic apparatus and instruments for diagnostic and therapeutic use; Orthopedic devices for diagnostic and therapeutic use; Radiological apparatus for diagnostic and medical purposesmagnetic resonance imager; Radiological apparatus for diagnostic and medical purposesa helium-3 polarizer used for magnetic resonance imaging (MRI) of the lungs; Sample preparation device for medical diagnostic uses; Ultrasonic bone densitometer with computerprintercomputer software for use therewithsold as a unitfor medical diagnostic use; Ultrasonic medical diagnostic apparatus; Ultrasound diagnostic apparatus; X-ray diagnostic apparatus
Publicações
Histórico de despachos e eventos da marca no USPTO.
57 publicações encontradas
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
05/06/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
05/06/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/06/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
27/12/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
17/03/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
17/01/2024
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
17/01/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
17/01/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
17/01/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
08/04/2021
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/04/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/04/2021
E815
TEAS SECTION 8 & 15 RECEIVED
23/12/2020
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
17/03/2020
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
23/05/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
17/03/2015
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/02/2015
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/02/2015
SUPC
STATEMENT OF USE PROCESSING COMPLETE
31/01/2015
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
30/01/2015
IUAF
USE AMENDMENT FILED
21/12/2014
EISU
TEAS STATEMENT OF USE RECEIVED
21/12/2014
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/09/2014
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
23/07/2014
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/07/2014
PUBO
PUBLISHED FOR OPPOSITION
08/07/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
18/06/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/06/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/06/2014
XAEC
EXAMINER'S AMENDMENT ENTERED
04/06/2014
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/06/2014
GNEA
EXAMINERS AMENDMENT E-MAILED
04/06/2014
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/06/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/05/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/05/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/05/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/11/2013
GNRT
NON-FINAL ACTION E-MAILED
11/11/2013
CNRT
NON-FINAL ACTION WRITTEN
11/11/2013
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
21/10/2013
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
15/04/2013
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
12/10/2012
ALIE
ASSIGNED TO LIE
10/10/2012
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
10/04/2012
GNSL
LETTER OF SUSPENSION E-MAILED
10/04/2012
CNSL
SUSPENSION LETTER WRITTEN
10/04/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
26/03/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
26/03/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
26/03/2012
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/01/2012
GNRT
NON-FINAL ACTION E-MAILED
06/01/2012
CNRT
NON-FINAL ACTION WRITTEN
06/01/2012
DOCK
ASSIGNED TO EXAMINER
05/01/2012
MDSC
NOTICE OF DESIGN SEARCH CODE MAILED
16/11/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
15/11/2011
NWAP
NEW APPLICATION ENTERED
11/11/2011
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SKYLA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.